BioUtah Enters M.O.U. with Hangshou Yuhang Economic-Technological Development Area
February 7, 2020
BioUtah was contacted last fall by James Moore, a Utah native, who now serves as the Senior Government Consultant, Entrepreneurship and Innovation Bureau, Hangshou Yuhang Economic-Technological Development Area. In late January, Mr. Moore was accompanied by representatives of industry in Hangzhou to explore opportunities for a mutual relationship in between Hangzhou and Utah. Specific interest was expressed in connecting with the life sciences industry in Utah. One company from Hangzhou, Diagens, met with several local medical device manufacturers to discuss the possibility of a mutual relationship wherein Diagens could partner in assisting to get products approved in China, manufactured in China and/or distributed through Diagens. Another entrepreneur was interested in the possibility of setting up an incubator type operation in Utah.
There were also discussions about the incentives being offered by the Hangzhou District for life science manufacturers and the plans to make Hangzhou District a premier manufacturer of life science products. Its location allows for lower cost of operations while still having access to large metropolitan areas.
An MOU was signed between the Hangzhou District, World Trade Center Utah and BioUtah indicating a desire to work together for the common good of all parties. BioUtah is grateful to James Moore for making Utah a top priority in their economic development plans in China and welcomes the opportunity to explore the possibilities for future economic development.
Recent News
- Myriad Genetics Highlights New Research Advancements and Oncology Innovations at 2025 ASCO Annual Meeting
- BD to Initiate Real-World Patient Data Registry for the Rotarex™ Atherectomy System in Treatment of Peripheral Artery Disease
- Lessons in Innovation: Clark Turner’s Impact on Medical Imaging
- Merit Medical Acquires Biolife Delaware
- Pathos AI Secures $365 Million in Series D Financing to Advance Oncology Drug Development Through AI
- BD Launches Landmark Cell Analyzer Featuring Breakthrough Spectral and Real-Time Cell Imaging Technologies